Revenue
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | £14.21B | £14.17B | £14.61B | £14.45B | £13.23B | £13.99B |
| Gross profit | £8.63B | £8.60B | £8.76B | £8.36B | £7.68B | £8.44B |
| Gross margin | 60.78% | 60.66% | 59.97% | 57.85% | 58.00% | 60.28% |
| Research & development | £316.0M | £325.0M | £337.0M | £325.0M | — | — |
| Operating expenses | £4.42B | £6.17B | £6.23B | £5.11B | £8.48B | £6.28B |
| Operating income | £4.22B | £2.42B | £2.53B | £3.25B | −£804.0M | £2.16B |
| Operating margin | 29.69% | 17.11% | 17.33% | 22.48% | −6.08% | 15.44% |
| EBITDA | £4.76B | £2.96B | £3.18B | £3.90B | — | — |
| EBITDA margin | 33.51% | 20.88% | 21.77% | 27.01% | — | — |
| Net income | £3.19B | £1.43B | £1.66B | £2.35B | −£21.0M | £1.20B |
| Net profit margin | 22.44% | 10.08% | 11.34% | 16.25% | −0.16% | 8.60% |
| Basic EPSper basic share | £4.68 | £2.04 | £2.29 | £3.26 | -£0.05 | £1.67 |
| Diluted EPSper diluted share | £4.67 | £2.03 | £2.29 | £3.25 | -£0.05 | £1.66 |